Company: RPID
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001380106-25-000174
Chunk: 347

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 8
Chunk 347
---
1 million for the six months ended June 30, 2025 and 2024, respectively.  Financing lease cost includes asset amortization on a straight-line basis over the lease term and interest accretion calculated using the effective interest method. Total financing lease asset depreciation and interest expense was less than $0.1 million for each of the three and six months ended June 30, 2025 and 2024.

25

Maturities of the Company’s operating lease liabilities as of June 30, 2025 were as follows (in thousands):Operating Lease Maturities2025 (excluding the six months ended June 30)$688 20261,401 20271,435 20281,469 2029804 Total lease payments$5,797 Less imputed interest(421)Total present value of lease liabilities$5,376 Maturities of the Company’s financing lease liability as of June 30, 2025 were as follows (in thousands):Financing Lease Maturities2025 (excluding the six months ended June 30)$37 202675 202775 202875 202938 Total lease payments$300 Less imputed interest(97)Total present value of lease liabilities$203 

14. Commitments and contingencies

Supplier agreementsIn the ordinary course of business, the Company has and may in the future enter into agreements with suppliers  that may require the Company to purchase or pay minimum or fixed amounts over the duration of the agreement.  The Company currently has minimum purchase commitments of $0.8 million, $1.8 million, and $1.6 million expected to be incurred for the remainder of 2025, 2026, and 2027, respectively, under such agreements.  These commitments are accrued as a liability when it is probable that a related future expenditure will be made, and such expenditure can be reasonably estimated.  Indemnification agreementsIn the ordinary course of business, the Company may provide indemnification of varying scope and terms to customers, vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its board of directors and certain of its executive officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of